Oral non-Hodgkin's lymphoma: review of the literature and World Health Organization classification with reference to 40 cases
S Kemp, G Gallagher, S Kabani, V Noonan… - Oral Surgery, Oral …, 2008 - Elsevier
Forty cases of oral cavity non-Hodgkin's lymphoma (NHL) were evaluated for sex, age,
location, clinical presentation, and World Health Organization (WHO) histological subtype …
location, clinical presentation, and World Health Organization (WHO) histological subtype …
Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature
K Triantafillidou, J Dimitrakopoulos, F Iordanidis… - Journal of Oral and …, 2012 - Elsevier
PURPOSE: Approximately one third of non-Hodgkin lymphomas (NHLs) arise in tissues
other than the lymph nodes. The purposes of this study are to evaluate the clinical outcome …
other than the lymph nodes. The purposes of this study are to evaluate the clinical outcome …
[HTML][HTML] The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald, G Wright, A Wiestner, WC Chan… - Cancer cell, 2003 - cell.com
We used gene expression profiling to establish a molecular diagnosis of mantle cell
lymphoma (MCL), to elucidate its pathogenesis, and to predict the length of survival of these …
lymphoma (MCL), to elucidate its pathogenesis, and to predict the length of survival of these …
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma
RI Fisher, SH Bernstein, BS Kahl… - Journal of clinical …, 2006 - ascopubs.org
Purpose Evaluate response rate, duration of response (DOR), time-to-progression (TTP),
overall survival (OS), and safety of bortezomib treatment in patients with relapsed or …
overall survival (OS), and safety of bortezomib treatment in patients with relapsed or …
Inhibition of constitutive NF-κB activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis
LV Pham, AT Tamayo, LC Yoshimura, P Lo… - The Journal of …, 2003 - journals.aai.org
Constitutive activation of the NF-κB has been documented to be involved in the
pathogenesis of many human malignancies, including hemopoietic neoplasms. In this study …
pathogenesis of many human malignancies, including hemopoietic neoplasms. In this study …
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma
T Haritunians, A Mori, J O'Kelly, QT Luong, FJ Giles… - Leukemia, 2007 - nature.com
Mantle cell lymphoma (MCL) is an aggressive form of B-cell non-Hodgkin's lymphoma, with
a mean survival of only 3–5 years and suboptimal therapeutic options. MCL is characterized …
a mean survival of only 3–5 years and suboptimal therapeutic options. MCL is characterized …
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma
D Albano, G Bosio, N Bianchetti, C Pagani… - Annals of Nuclear …, 2019 - Springer
Objective Mantle cell lymphoma (MCL) is an aggressive lymphoma sub-type with poor
prognosis and high 18F-FDG avidity at PET/CT; nowadays, no validated criteria for PET/CT …
prognosis and high 18F-FDG avidity at PET/CT; nowadays, no validated criteria for PET/CT …
Mantle cell lymphoma in the ocular adnexal region
A Looi, RD Gascoyne, M Chhanabhai, JM Connors… - Ophthalmology, 2005 - Elsevier
PURPOSE: To study the clinicopathologic features of mantle cell lymphoma (MCL) in the
ocular adnexal region. DESIGN: Retrospective review. METHODS: The slides of 23 suspect …
ocular adnexal region. DESIGN: Retrospective review. METHODS: The slides of 23 suspect …
[HTML][HTML] A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
F Morschhauser, JF Seymour, HC Kluin-Nelemans… - Annals of oncology, 2008 - Elsevier
Background Protein kinase C beta (PKCβ), a pivotal enzyme in B-cell signaling and survival,
is overexpressed in most cases of mantle cell lymphoma (MCL). Activation of PI3K/AKT …
is overexpressed in most cases of mantle cell lymphoma (MCL). Activation of PI3K/AKT …
Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease
E Even-Sapir, G Lievshitz, C Perry, Y Herishanu… - Radiologic Clinics of …, 2007 - Elsevier
Lymphoma may originate in extranodal sites. Extranodal lymphoma may also be secondary
to and accompany nodal disease. Fluorine-18 fluorodeoxyglucose (18F-FDG) imaging has …
to and accompany nodal disease. Fluorine-18 fluorodeoxyglucose (18F-FDG) imaging has …